Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4781615
Max Phase: Preclinical
Molecular Formula: C131H209IN34O28
Molecular Weight: 2835.23
Molecule Type: Unknown
Associated Items:
ID: ALA4781615
Max Phase: Preclinical
Molecular Formula: C131H209IN34O28
Molecular Weight: 2835.23
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(=N)N)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](Cc2ccc(I)cc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccc(-c3ccccc3)cc2)C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)O
Standard InChI: InChI=1S/C131H209IN34O28/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-44-109(170)153-97(126(187)188)54-56-108(169)144-62-66-191-68-70-193-80-110(171)145-63-67-192-69-71-194-81-111(172)152-92(37-24-27-58-146-128(135)136)114(175)155-93(39-29-60-148-130(139)140)115(176)156-94(53-55-107(134)168)116(177)157-96(38-25-28-59-147-129(137)138)124(185)164-64-31-42-103(164)119(180)158-95(40-30-61-149-131(141)142)123(184)163(4)105(72-83(2)3)121(182)162-101(79-167)118(179)159-98(76-90-77-143-82-151-90)117(178)154-91(36-23-26-57-133)113(174)150-78-112(173)166-102-41-22-21-35-88(102)75-106(166)122(183)160-99(73-85-47-51-89(132)52-48-85)125(186)165-65-32-43-104(165)120(181)161-100(127(189)190)74-84-45-49-87(50-46-84)86-33-18-17-19-34-86/h17-19,33-34,45-52,77,82-83,88,91-106,167H,5-16,20-32,35-44,53-76,78-81,133H2,1-4H3,(H2,134,168)(H,143,151)(H,144,169)(H,145,171)(H,150,174)(H,152,172)(H,153,170)(H,154,178)(H,155,175)(H,156,176)(H,157,177)(H,158,180)(H,159,179)(H,160,183)(H,161,181)(H,162,182)(H,187,188)(H,189,190)(H4,135,136,146)(H4,137,138,147)(H4,139,140,148)(H4,141,142,149)/t88-,91-,92-,93+,94-,95+,96-,97-,98-,99-,100+,101-,102-,103-,104-,105-,106-/m0/s1
Standard InChI Key: BUDKLOQRAPRGJV-ZSBQYRKRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2835.23 | Molecular Weight (Monoisotopic): 2833.5020 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Reed AB,Lanman BA,Holder JR,Yang BH,Ma J,Humphreys SC,Wang Z,Chan JCY,Miranda LP,Swaminath G,Allen JG. (2020) Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation., 30 (21.0): [PMID:32858124] [10.1016/j.bmcl.2020.127499] |
Source(1):